Science ❯ Biotechnology

Clinical Trials

Psychedelic Research Drug Approval Nasal COVID-19 Vaccine Cancer Immunotherapy Gene Mutation Obesity Treatment Phase 3 Studies Human Trials Safety Testing Cancer Treatment Research and Development Immunotherapy Health Innovations Drug Development Stages Gene Therapy Research Innovation Cancer Research Drug Development Trial Design Metabolic Diseases Machine Learning Antibodies Phase 3 Trials Medical Research

Senhwa Signs MOU With GEM for Up to NT$500 Million to Speed AI-Driven Cancer R&D

The pledge is non-binding and will depend on definitive agreements before funds are released.

DBV Technologies Files 2025 Annual Report, Extends Runway as 2026 Peanut Patch Filings Near

Gilead to Buy Ouro Medicines for $1.675 Billion Upfront to Advance Autoimmune T‑Cell Engager

Viking Therapeutics Pushes VK2735 Through Pivotal Trials as Next Enrollment Milestone Nears

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug

Sarepta Shares Plunge After ESSENCE Phase 3 Miss in Duchenne Trial

FDA Setback Puts uniQure’s Huntington’s Gene Therapy Filing in Doubt

First Human Trial Finds Enteral Ventilation Procedure Tolerable in Healthy Volunteers

Samsung Invests $110 Million in Grail to Bring Galleri Cancer Test to Asia

AbbVie Agrees to Buy Gilgamesh’s Bretisilocin for Up to $1.2 Billion

FDA Rejects Replimune’s RP1 Melanoma Immunotherapy